Dr. Maalouf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-2870Fax+1 214-645-2871
Summary
- Dr. Naim Maalouf is an endocrinologist in Dallas, TX. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 19 years. He specializes in disorders of calcium, parathyroid, and bone metabolism, and in the medical evaluation and management of kidney stone disease.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2004
- Emory University School of MedicineResidency, Internal Medicine, 1998 - 2001
- American University of Beirut Faculty of MedicineClass of 1998
- American University of BeirutB.S., Chemistry, 1994
Certifications & Licensure
- TX State Medical License 2004 - 2026
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Frederic C. Bartter Professorship in Vitamin D Research UT Southwestern Medical Center, 2014
- Named “Top Doctor” U.S. News and World Report, 2011
- Join now to see all
Clinical Trials
- Treatment for Calcium Phosphate Kidney Stone Disease Start of enrollment: 2012 Jul 01
- Prevention of Urinary Stones With Hydration Start of enrollment: 2017 Oct 04
Publications & Presentations
PubMed
- 165 citationsThe effects of smoking on bone metabolismVivienne Yoon, Naim M. Maalouf, Khashayar Sakhaee
Osteoporosis International. 2012-02-21 - 154 citationsUrine Composition in Type 2 Diabetes: Predisposition to Uric Acid NephrolithiasisMary Ann Cameron, Naim M. Maalouf, Beverley Adams-Huet, Orson W. Moe, Khashayar Sakhaee
Journal of the American Society of Nephrology. 2006-05-01 - 1018 citationsSeverely Suppressed Bone Turnover: A Potential Complication of Alendronate TherapyClarita V. Odvina, Joseph E. Zerwekh, D. Sudhaker Rao, Naim M. Maalouf, Frank A Gottschalk
The Journal of Clinical Endocrinology and Metabolism. 2005-03-01
Journal Articles
- A Utilization of NHANES to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in 2030Antonelli JA, Maalouf NM, Pearle MS, Lotan Y, Eur Urol, 1/1/2014
- The Impact of Obesity on the Presentation of Primary HyperparathyroidismTran H, Grange JS, Adams-Huet B, Nwariaku FE, Rabaglia JL, Woodruff SL, Holt SA, Maalouf NM, J Clin Endocrinol Metab, 1/1/2014
- Animal Protein and the Risk of Kidney Stones: A Comparative Metabolic Study of Animal Protein SourcesTracy CR, Best S, Bagrodia A, Poindexter JR, Adams-Huet B, Sakhaee K, Maalouf N, Pak CY, Pearle MS, J Urol, 1/1/2014
- Join now to see all
Books/Book Chapters
Lectures
- Kidney Stones: Diagnosis, Management, and PreventionENDO 2019 - New Orleans, LA - 3/24/2019
- Pioglitazone Increases Femoral Neck Bone Marrow Fat Content and Proportionately Reduces Total Hip Bone Mineral DensityChicago, IL - 1/1/2014
- Lifestyle and Bone HealthDallas, TX - 1/1/2014
- Join now to see all
Press Mentions
- Calcium Supplements Don’t Raise Heart Attack RiskApril 16th, 2016
Grant Support
- Mentored Patient-Oriented Research Career Development AwardNational Center For Research Resources2005–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: